246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid

Vas Narasimhan, CEO of Novartis and the new chairman of PhRMA, joins us to discuss the industry’s struggles in Washington and whether the deflated biotech sector is still overvalued. We also dive into the latest news in the life sciences, including Moderna's promise of no-cost Covid-19 vaccines and biotech entrepreneur Vivek Ramaswamy's potential run for president.

Episode metadata supplied by the publisher feed · Published Feb 16, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid

0:00 40:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 40 minutes long.

When was this The Readout Loud episode published?

This episode was published on February 16, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!